Overview
Keisuke Sugita practices in Tokyo, Japan. Mr. Sugita is rated as an Advanced expert by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Virilizing Ovarian Tumor, Sertoli-Leydig Cell Tumor, Small Cell Lung Cancer (SCLC), and Lung Cancer.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Virilizing Ovarian Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Virilizing Ovarian TumorMr. Sugita isAdvanced. Learn about Virilizing Ovarian Tumor.
- Experienced
- Lung CancerMr. Sugita isExperienced. Learn about Lung Cancer.
- Sertoli-Leydig Cell TumorMr. Sugita isExperienced. Learn about Sertoli-Leydig Cell Tumor.
- Small Cell Lung Cancer (SCLC)Mr. Sugita isExperienced. Learn about Small Cell Lung Cancer (SCLC).